Information Provided By:
Fly News Breaks for November 9, 2015
CTIC
Nov 9, 2015 | 07:15 EDT
WallachBeth analyst Bob Ai downgraded CTI BioPharma to Hold and lowered his price target to $1.60 from $4.50 after the company cut its 2015 revenue outlook.
News For CTIC From the Last 2 Days
There are no results for your query CTIC